2027 ACMT Annual Scientific Meeting | #ACMT2027
Includes a Live In-Person Event on 04/01/2027 at 7:40 AM (CDT)
-
Register
- Early bird pricing available!
- Non-member - Tier I - $1,050
- Non-member - Tier II - $700
- Non-member - Tier III - $550
- Non-member - Tier IV - $450
- Member - Tier I - $750
- Member - Tier II - $500
- Member - Tier III - $350
- Member - Tier IV - $250
- Regular Price after 02/18/2027 11:59 PM
- Non-member - Tier I - $1,200
- Non-member - Tier II - $850
- Non-member - Tier III - $700
- Non-member - Tier IV - $600
- Member - Tier I - $900
- Member - Tier II - $650
- Member - Tier III - $500
- Member - Tier IV - $400
#ACMT2027 | Annual Scientific Meeting
April 1-3, 2027
Sheraton New Orleans Hotel, New Orleans, LA
The 2027 ACMT Annual Scientific Meeting (#ACMT2027) will take place from April 1-3 at the Sheraton New Orleans Hotel in New Orleans, LA. This event offers a unique opportunity for medical toxicology specialists to gather, learn, and network. Attendees will be exposed to cutting-edge research through a variety of educational sessions and tracks. The meeting will also provide rich social and networking opportunities with receptions, business meetings, and awards ceremonies. Participants will leave equipped to enhance clinical decision-making, stay updated on emerging toxins and therapies, and foster multidisciplinary collaboration in managing complex toxicology cases. Continuing Education credits for Physicians, Pharmacists, and Nurses available.
AACT Member Discount: AACT Members who are not already ACMT members, are eligible to receive a discounted registration rate. Just enter the following code at checkout to receive a $50 discount. Discount code: AACT2027
Learner Objectives
After attending the event, participants should be able to:
- Enhance clinical decision-making in the field of Medical Toxicology.
- Summarize knowledge of emerging toxins and novel therapies.
- Organize multidisciplinary collaboration in the management of complex medical toxicology cases.

Continuing Education
Live and Enduring continuing education credits for Physicians and Pharmacists is provided by AKH Inc., Advancing Knowledge in Healthcare. It is expected that learners will receive up to 16.00 credits for learning and change.
You may also be interested in:
AACT Bayou Tox Symposium ACMT Chemical & Radiation Symposium
ACMT Addiction Updates Symposium
Questions?
Please write to ACMT at [email protected]
Registration Rates
Registration includes:
- Access to the live in-person event on April 1-3, 2027
- Access to the on-demand recording for 90 days after the event
- Access to the speaker slides
- Continuing Education credits available for Physicians and Pharmacists
| ACMT Member Rates | Early-Bird Expires: Feb 18, 2027 | Regular Rate Begins: Feb 19, 2027 |
|---|---|---|
Member Tier I: Full, Affiliate, International, Emeritus |
$750 | $900 |
Member Tier II: Fellows |
$500 | $650 |
Member Tier III: Residents, International - Developing Country |
$350 | $500 |
Member IV: Medical Students |
$250 | $400 |
| Non-Member Rates | Early-Bird Expires: Feb 18, 2027 | Regular Rate Begins: Feb 19, 2027 |
|---|---|---|
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other" |
$1050 | $1200 |
Non-member Tier II: Fellows, SPIs, Nurses, etc. |
$700 | $850 |
Non-member Tier III: Educators & Emergency Responders |
$550 | $700 |
Non-member IV: Residents & Students | $450 | $600 |
Early-Bird Rate
Early-bird rates expire at midnight on FEBRUARY 18, 2027. Fees increase to the Regular Rate after this date, no exceptions.
Membership Discounts
ACMT Members: ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at [email protected]. Learn more at: www.acmt.net/membership
AACT Member Discount: AACT Members who are not already ACMT members, are eligible to receive a discounted registration rate. Just enter the following code at checkout to receive a $50 discount. Discount code: AACT2027
Refunds and Cancellations
Event registration cancellations received on or before February 16, 2027 (2/16/27) will receive a full refund less a 8% processing fee. Cancellations received between February 16, 2027 and March 18, 2027 (2/16/27-3/18/27) will receive a 50% refund. Cancellations made on or after March 18, 2026 (3/18/27) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.
All cancellation requests must be made in writing and emailed to: [email protected]. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to [email protected]. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
For any questions, please email us at [email protected].
Spots are still open to present at ACMT! Take a look at the opportunities below before applications close.
MedTox Case Panel: Case-Based Conundrums
The Education Committee invites Fellows-in-Training and ACMT Members to submit a case of a unique or interesting patient for presentation at the MedTox Case Panel: Case-Based Conundrums taking place during the 2027 ACMT Annual Scientific Meeting, April 1-3, 2027 in New Orleans.
Three cases will be selected for presentation and discussion by a panel of Medical Toxicology specialists. All cases will be considered, but there is a specific interest in complex or controversial management issues encountered by the medical toxicologist.
Deadline to apply is January 5, 2027.
ACMT Open Mic Competition
The ACMT Open Mic Competition offers medical toxicology fellows-in-training, residents, and medical students the opportunity to give a lecture in a national forum where experienced speakers can offer insight on both content and delivery.
Any topic relevant to medical toxicology is appropriate—historical topics, mystery cases, molecular mechanisms, educational development, etc. Above all, we are looking for engaging speakers and interesting presentations. Presenters are chosen by a panel of evaluators. Proposals are evaluated on content and originality.
Deadline to apply is January 5, 2027.
The ACMT Catalyst Program
The ACMT Catalyst Program provides a unique opportunity for future toxicologists to gain behind-the-scenes access to the ACMT Annual Scientific Meeting while building meaningful connections with leaders, fellows, and physicians in the field.
Selected participants will serve as conference volunteers and representatives while participating in educational sessions, networking events, and mentorship opportunities throughout the meeting. Ambassadors will work alongside ACMT staff and leadership, gaining valuable experience in conference operations and professional engagement while learning more about the specialty of medical toxicology.
Deadline to apply is November 15, 2026.The Tox Case Exchange
The ACMT Education Committee invites submissions for the inaugural ACMT Tox Case Exchange at the 2027 ACMT Annual Scientific Meeting in New Orleans, LA on Wednesday March 31, 2027.
The forum is specifically designed for trainee-presented cases that are educational rather than necessarily novel, including classic poisonings, diagnostic challenges, management dilemmas, interesting ECGs/imaging, and cases that sparked discussion or changed clinical practice.
This interactive, non-CME forum is designed to showcase educational toxicology cases presented by trainees. We are seeking classic poisonings, diagnostically challenging cases, uncommon presentations, management dilemmas, and other cases that offer high educational value for medical toxicologists. The goal is to create an engaging forum for discussion, networking, and shared learning among trainees including students, residents, and fellows.
This meeting will be fully in-person. Presenters will be required to register for the meeting and present in-person. There will be no virtual option.
Deadline to apply is November 15, 2026.
Agenda
Click on the link below to access the most up-to-date agenda. All times listed in local, Central time.
Ann Arens, MD
Medical Director, Division of Medical Toxicology; Associate Professor of Emergency Medicine
Ochsner Medical Center; Xavier Ochsner College of Medicine and University of Queensland Ochsner Clinical School
Dr. Arens is an Emergency Medicine physician who practices at Ochsner Medical Center in New Orleans, LA. Dr. Arens completed her Emergency Medicine training at the Denver Health Residency in Emergency Medicine, and her medical toxicology training at the University of California – San Francisco. She was amongst the first toxicologists to identify and describe counterfeit fentanyl products, and has continued to identify outbreaks of new drugs of abuse. She has a broad range of research interests including: the identification of new drugs of abuse including novel opioids contributing to the current opioid epidemic, the use of antidotes, and advanced supportive care of the poisoned patient.
Kavita Babu, MD, FACMT
Chief Medical Officer and Vice President of Medical Affairs
Heywood Healthcare
Dr. Kavita Babu serves as Chief Medical Officer and Vice President of Medical Affairs at Heywood Healthcare, where she provides strategic and clinical leadership to advance high-quality, patient-centered care across the organization.
A highly respected physician executive and emergency medicine leader, Dr. Babu brings more than 20 years of experience spanning clinical care, healthcare operations, and executive leadership. She has led numerous initiatives focused on quality improvement, patient safety, physician engagement, and operational excellence, while also playing a key role in expanding substance use disorder services and strengthening community-based care delivery.
Known for her collaborative and multidisciplinary approach, Dr. Babu has worked closely with medical staff, nursing, pharmacy, emergency medical services, and executive teams to enhance care delivery, improve access, and optimize clinical performance. She remains an active practicing emergency physician and is widely recognized for her expertise in addiction medicine, medical toxicology, clinical informatics, and healthcare operations.
Dr. Babu earned her Doctor of Medicine from Brown Medical School after completing her undergraduate studies in Biology at Brown University. She completed her residency in Emergency Medicine at Brown and a fellowship in Medical Toxicology at the University of Massachusetts. She also holds an MBA from the Isenberg School of Management at the University of Massachusetts Amherst.
Dania Mariel Felix Bernstorff, MD
Emergency Medicine Physician & Clinical Toxicologist
Centro Toxicológico Hospital Ángeles Lomas
Dania Mariel Felix Bernstorff, MD, is a clinical toxicologist with extensive experience in emergency toxicology and medical education. She is a member of the Mexican Association of Emergency and Disaster Medicine (AMUDEM) and Co-Chair of the International Committee of the American College of Medical Toxicology (ACMT). She is recognized for her work in research and the dissemination of toxicology in Latin America.
Kayla Bourgeois, PharmD, DABAT
Clinical Toxicologist, Emergency Medicine Pharmacist
University of Maryland School of Pharmacy / Maryland Poison Center
Dr. Bourgeois is a board-certified clinical toxicologist and emergency medicine pharmacist with a strong background in poison center operations, toxicologic data informatics, and pharmacovigilance. She has clinical expertise spanning emergency medicine, toxicology, and public health. Dr. Bourgeois brings a dynamic blend of teaching, clinical service, and research, with special focus on the analysis of emerging substances and improving patient outcomes through poison center data insights and drug safety monitoring.
Jennie Buchanan, MD, FACMT
Fellowship Director & Professor of Emergency Medicine
University of Colorado, Rocky Mountain Poison & Drug Safety
Jennie Buchanan, MD, FACEP, has served as the senior module editor for PEER Social and Behavioral Health since 2020. Dr. Buchanan is currently an associate professor in the Department of Emergency Medicine at Denver Health and Hospital Authority/University of Colorado School of Medicine as well as associate program director for the Denver Health Residency in Emergency Medicine. She also serves as clinical faculty and toxicologist for Rocky Mountain Poison and Drug Safety in Denver, a physician advisor for the Sexual Assault Nurse Examiners (SANEs), a Denver Health Nurseline physician, and a faculty advisor and longitudinal integrated curriculum section director in emergency medicine for Denver Health. Dr. Buchanan earned her doctor of medicine degree from the University of California San Diego School of Medicine. She completed an internship in reproductive medicine at the University of California San Diego School of Medicine; residency training in emergency medicine at Denver Health and Hospital Authority, where she served as chief resident elect; a fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center; and certification in emergency medicine ultrasound. Dr. Buchanan previously served as cochair for the State of Colorado SANE.
Stephanie Carreiro, MD, PhD, FACMT
Vice Chair of Research and Associate Professor of Emergency Medicine
University of Massachusetts Chan Medical School
Dr. Stephanie Carreiro is a physician-scientist at the forefront of digital health innovation in emergency medicine and medical toxicology. As an Associate Professor, Vice Chair of Research, and Director of the Tox(In)novation Lab at the University of Massachusetts Chan Medical School, she leads groundbreaking work that blends clinical expertise with cutting-edge technology to transform how we prevent, detect, and treat substance use disorders. Her research centers on digital phenotyping, digital therapeutics, and understanding how real-world patterns of technology use can inform interventions and promote health equity.
She earned her MD from New York Medical College in 2009, completed emergency medicine residency training at Brown University in 2013, and went on to complete a medical toxicology fellowship (2015) and a PhD in Biomedical Sciences (2022) at the University of Massachusetts. This foundation in both clinical medicine and biomedical research underpins her mission to develop practical, evidence-based digital solutions that improve patient outcomes and expand access to care.
Dr. Carreiro leads a diverse portfolio of industry-sponsored and federally funded research, including awards from the National Institute on Drug Abuse and the National Institute of Biomedical Imaging and Bioengineering. Across these projects, her goal is the same: to turn data into actionable insights, translate technology into real-world impact, and build digital tools that are as accessible as they are effective.
David K Carroll, MD
Medical Toxicologist
Michigan Poison and Drug Information Center
Dr. David Carroll is a Medical Toxicologist at Michigan Poison and Drug Information Center and Assistant Professor of Emergency Medicine, Wayne State University SOM.
Alexis L. Cates, DO, FACEP
Emergency Medicine and Medical Toxicology Staff Physician, Assistant Professor of Emergency Medicine - The University of Queensland/Ochsner Clinical School
Ochsner Medical Center
Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA. She is currently located at Ochsner Medical Center in New Orleans, LA where she serves as the Emergency Medicine Residency Assistant Program Director and the Resident Medical Toxicology Rotation director. Professionally, she enjoys academics, perinatal toxicology, and health policy. She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.
Peter Chai, MD, MMS
Associate Professor
Brigham and Women's Hospital
Dr. Peter R Chai is an associate professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states. Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.
Angela Chiew, PhD
Emergency Physician and Clinical Toxicologist
Prince of Wales Hospital
Prof Angela Chiew is a Clinical Toxicologist and Emergency Medicine Physician at Prince of Wales Hospital, Randwick and as a Clinical Toxicologist for the NSW Poison’s Information Centre. She has completed her PhD in Paracetamol Poisoning in 2020 through Sydney University. She performs research into paracetamol poisoning and her major contribution has been the establishment of the Australian Toxicology Monitoring (ATOM) Study. ATOM is a prospective observational study recruiting patients from across NSW and Queensland with poisoning. She is on the editorial boards of British Journal of Clinal Pharmacology and Clinical Toxicology, and is the lead author of the Australian and New Zealand Paracetamol Guidelines published in 2015 and 2019. She has just been appointed the Lead Clinical Toxicologist overseeing and managing the NSW Poisons Information Centre Research Portfolio.
Sandra Comer, PhD
Professor of Neurobiology, Department of Psychiatry
Columbia University
Dr. Sandra Comer is a Professor of Neurobiology in the Department of Psychiatry at Columbia University. She received her BS at Vanderbilt University and PhD at the University of Michigan for her research on the effects of drugs using preclinical models. Dr. Comer is Director of the Opioid Laboratory in the Division on Substance Use Disorders and her current research focus is on the clinical testing of medications for treating opioid use disorder, methods to maximize the use of naloxone by opioid users, and evaluations of the comparative abuse liability of prescribed pain medications. Dr. Comer served as President of the College on Problems of Drug Dependence, the longest standing scholarly society in the U.S. devoted to research on substance use disorders, and currently is the Public Policy Officer for CPDD. She joined the Expert Advisory Panel on Drug Dependence for the WHO and has over 150 publications on substance use disorders.
Colton Cooper, MPH
Environmental Epidemiologist
New Mexico Department of Health
Colton Cooper is a water epidemiologist with the New Mexico Department of Health, where he investigates how contaminants in private wells and small water systems affect human health. His work bridges environmental monitoring, toxicology, and public health communication to support safe drinking water across rural communities.
Originally from Huntington, West Virginia, Colton earned his Master of Public Health in Environmental Health and Epidemiology from Emory University. His current projects include emerging contaminant risk mapping, PFAS exposure assessment, and health-based guidance for water systems.
Larry D. Cowgill, DVM, PhD, DACVIM (SAIM), ACVNU (Founder)
Distinguished Professor Emeritus/Veterinary Medical Director
School of Veterinary Medicine, UC Davis/Aimalojic Animal Health, Rapid City
Dr. Larry Cowgill received his DVM degree from UC Davis and completed internship and residency training in internal medicine at the University of Pennsylvania. He was a NIH Special Research Fellow at the Renal and Electrolyte Section of the University of Pennsylvania School of Medicine and earned a PhD in comparative medical sciences. He is board certified in small animal internal medicine and Founder of the American College of Veterinary Nephrology and Urology. He was a professor in the Department of Medicine and Epidemiology of the UC Davis School of Veterinary Medicine for 48 years. He developed and oversaw the clinical nephrology programs and the companion animal extracorporeal services at the UC Davis and the UCVMC-SD. Dr. Cowgill has more than 55 years of experience in veterinary internal medicine, nephrology, and teaching, and has trained many of the leading veterinary nephrologists throughout the world. He is a pioneer in the application of extracorporeal therapies in companion animals and remains a leading authority in the development of blood purification therapies for renal diseases in animals and people.
Bram Dolcourt, MD
Clinical Assistant Professor Department of Emergency Medicine
Wayne State University
Bram Dolcourt is Assistant Professor of Emergency Medicine at Wayne State University and serves as Associate Residency Director for Emergency Medicine at Sinai Grace Hospital in Detroit. Dr. Dolcourt is a Clinical Consultant to the Michigan Poison and Drug Information Center. Dr Dolcourt complete Medical School at New York Medical College and residency at Henry Ford Hospital. Dr. Dolcourt then went on to complete fellowship in Medical Toxicology at the Children’s Hospital of Michigan. Dr. Dolcourt’s interests include inpatient addiction medicine and heavy metal exposures.
John Downs, MD, MPH
Associate Professor and Director, Virginia Poison Center
Virginia Commonwealth University Health System
Dr. John W. Downs, MD, MPH, is a medical toxicology faculty member at Virginia Commonwealth University (VCU) and a retired U.S. Army officer with over 20 years of distinguished service. A graduate of the Virginia Military Institute and the Uniformed Services University (USU), he completed residencies in internal medicine and occupational & environmental medicine, as well as a fellowship in medical toxicology at VCU. Dr. Downs has extensive military medical experience, including multiple deployments as a senior medical officer for special operations and infantry units in Iraq and Afghanistan, and leadership roles such as Chief of Preventive Medicine at Fort Campbell and Chief of Occupational & Environmental Medicine at Walter Reed during the COVID-19 pandemic. Board certified in internal medicine, occupational & environmental medicine, and medical toxicology, he also holds certifications as a Certified Public Health professional (CPH) and Diplomate of the American Board of Toxicology (DABT). A Fellow of the American College of Physicians and the American College of Occupational and Environmental Medicine, Dr. Downs has authored over 25 peer-reviewed publications and is a recipient of the Army Surgeon General’s 9A Proficiency Designation.
Timothy B. Erickson, MD, FACEP, FACMT, FAACT
Emergency Medicine Physician, Division of Medical Toxicology
Brigham and Women’s Hospital
Dr. Erickson is an emergency medicine physician at Mass General Brigham in Boston, MA. He is the Division Chief of Medical Toxicology in the Department of Emergency Medicine. He is a Full Professor at Harvard Medical School and the Harvard Humanitarian Initiative (HHI). He is a Professor Emeritus at the University of Illinois where he established the UIC Center for Global Health. His areas of expertise include CBRNE response and training, environmental toxicology, crisis in climate change, wastewater epidemiology, and acute injuries from global conflict settings such as Ukraine, Syria, Kosovo, Sudan, and Rwanda. Over the past 3 decades he had conducted numerous projects and deployments to Ukraine with NATO and International Medical Corps (IMC).

Lindsey Claire Epperson, DO, MD
Medical Toxicologist & Emergency Medicine Physician
Integris Southwest Medical Center
Lindsey Claire Epperson, DO, is the associate medical director of the Oklahoma Center for Poison and Drug Information. She is board certified in emergency medicine and medical toxicology. She erned her medical degree at Oklahoma State University College of Osteopathic Medicine and completed residency in emergency medicine at Integris Southwest Medical Center in Oklahoma City. She completed her medical toxicology fellowship at the University of Texas Southwestern Medical Center in Dallas, Texas.
Lynn Farrugia, MD, FACMT
Director, Global Patient Safety & Risk Management
Alnylam Pharmaceuticals
Lynn Farrugia received her medical degree from Georgetown University and completed emergency medicine residency and medical toxicology fellowship at the University of Massachusetts. After working in academic medicine with roles including Director of Medical Toxicology, Medical Director of Occupational Health, and Medical Review Officer, she transitioned to a role as product lead safety physician with a biopharmaceutical company.
Charlotte Goldfine
Assistant Professor of Emergency Medicine and Medical Toxicology
Yale School of Medicine
Dr. Charlotte Goldfine is an Assistant Professor of Emergency Medicine at Yale School of Medicine and a medical toxicologist. Her clinical and research interests include substance use disorders, patient engagement in addiction treatment, and the use of digital health technologies to improve patient care. Her research combines technology and behavioral interventions to better understand substance use and support treatment, with an emphasis on developing practical tools informed by patient needs and experiences.
Her current NIH-funded K23 research focuses on digital interventions to support medication adherence among patients with alcohol use disorder and alcohol-associated liver disease. This work brings together collaborators across emergency medicine, addiction medicine, and hepatology to improve access to and engagement in treatment for alcohol use disorder.
Ryan Gumbleton, PharmD
Clinical Pharmacy Specialist
Detroit Medical Center, Detroit, MI
Ryan Gumbleton, based in Michigan, is currently a Medical Science Liaison at Aerogen. Ryan Gumbleton brings experience from previous roles at Detroit Medical Center and Sanford Health.
Carleigh Hebbard, PhD, MD
Toxicology Fellow, Emergency Medicine
Washington University in St. Louis
Dr. Carleigh Hebbard recently completed a combined Medical Toxicology and Research fellowship at Washington University in St. Louis, becoming the program's first fellow to pursue this integrated training pathway. She previously earned an MS in Microbiology, a PhD in Biochemistry, and an MD through the Medical Scholars Program at the University of Illinois Urbana-Champaign, and she subsequently completed her Emergency Medicine residency at The Ohio State University Wexner Medical Center.
Her research spans basic and translational science. Some of her previous work includes investigations into the molecular mechanisms of heart failure, pharmacokinetic and pharmacogenetic variability in cardiovascular drug responses, and the pathophysiology of obesity-associated cardiometabolic dysfunction. Most recently, she has worked in Dr. Samuel Klein’s laboratory studying the pleiotropic effects of GLP-1 receptor agonists, with a particular interest in their potential therapeutic applications for substance use disorders. Dr. Hebbard is an ACMT ANTIDOTE program mentee.
Robert Hendrickson, MD, FACMT
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health & Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Rob Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.

Amanda Holford
Emergency Physician and Clinical Toxicologist
Queensland Health
Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP
Professor of Emergency Medicine
SUNY Upstate Medical University
Dr. Michael Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.
Katherine Isoardi, MD
Emergency Physician and Clinical Toxicologist
Princess Alexandra Hospital
Katherine is an Emergency Physician and Clinical Toxicologist based at the Princess Alexandra Hospital and the Medical Director for the Queensland Poisons Information Centre. She is passionate about promoting and expanding Clinical Toxicology services throughout Queensland.
She is the president of Toxicology And Poisoning Network Australasia (TAPNA), serves on multiple TAPNA subcommittees, and facilitates its 2 year post-graduate Clinical Toxicology course. She also created the Princess Alexandra Hospital Clinical Toxicology Subspecialisation Program which allows post-graduate toxicology training for nurses and pharmacists.
David Jang, MD, MSc, FACMT
Assistant Professor
University of Pennsylvania School of Medicine
We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy.
Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy.
Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.

Andy Jochems
Source Water Protection Team Lead
New Mexico Environment Department
Andy Jochems has 15 years of combined experience in field geology and source water protection. He is passionate about using a scientific and equitable approach to address issues of water scarcity and quality.
Andy's professional and research interests include geologic mapping, arid-land geomorphology, environmental geology and contaminants of emerging concern, and basin-fill stratigraphy of the Rio Grande rift. He holds an M.S. in geology from Utah State University and a B.S. in environmental science from the University of New Mexico.
Linda Johnson, MD, PhD
Assistant Professor
UMass Chan Medical School
Eric Kaczor, MD
Medical Toxicologist
University at Buffalo
Dr. Eric E. Kaczor is an emergency medicine physician in Buffalo, New York and is affiliated with multiple hospitals in the area, including Kaleida Health-Buffalo General Medical Center and UMass Memorial Medical Center. He received his medical degree from University at Buffalo School of Medicine
Andrew King, MD
Professor
Wayne State University School of Medicine & Michigan Poison and Drug Information Center
Dr. King is the Medical Director of the Michigan Poison and Drug Information Center, Wayne State University/Detroit Medical Center Medical Toxicology Fellowship Program Director, and the Medical Director of the Tolan Park research clinic. He is board certified in emergency medicine, Medical Toxicology, and Addiction Medicine.
Joshua D. King, MD, FACMT
Associate Professor of Medicine and Pharmacy; Medical Director
University of Maryland; Maryland Poison Center
Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.
Michael J. Kosnett, MD, MPH, FACMT
Associate Clinical Professor, Department of Medicine
University of Colorado School of Medicine
Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”
Alex Krotulski, PhD
Director of Toxicology & Chemistry
The Center for Forensic Science Research and Education
Dr. Alex J. Krotulski serves as a Director at the Center for Forensic Science Research and Education (CFSRE) working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery, the CFSRE’s drug early warning system and flagship program for the identification and characterization of new and emerging synthetic drugs. Dr. Krotulski is a chemist by training and practices as a forensic toxicologist. Dr. Krotulski holds faculty appointment and serves as the Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and is an Senior Associate Editor for the Journal of Analytical Toxicology.
Cyrus Kuschner, MD
Fellow
Northwell Health
Dr. Kuschner graduated from the Donald and Barbara Zucker School of Medicine At Hofstra/Northwell in 2020. He works in Manhasset, NY and specializes in Emergency Medicine. He is currently a Medical Toxicology Fellow-in-Training at Northwell Health.
JoAn Laes, MD, DFASAM, FACMT
Addiction Staff Physician
Abbott Northwestern Hospital, Allina Health
JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.
Ophir Lavon, MD, FEAPCCT
Medical Toxicologist, Clinical Pharmacologist, & Internal Medicine Specialist
Director of Clinical Pharmacology and Toxicology, Carmel Medical Center
Dr. Ophir Lavon is a board-certified medical toxicologist, clinical pharmacologist, and internal medicine specialist. He is the director of the Clinical Pharmacology and Toxicology Unit at Carmel Medical Center (Haifa, Israel), and leads its fellowship program. Dr. Lavon is the current chairperson of the Israeli Society for Clinical Pharmacology and the immediate past chair of the Israel Society of Toxicology (both affiliated with the Israel Medical Association). Dr. Lavon is a board member of the European Association of Poison Centres and Clinical Toxicologists (EAPCCT) and serves as the chairperson of its Communication Committee. He is an active member of ACMT and AACT. Dr. Lavon is a senior lecturer at the Rappaport Faculty of Medicine of the Technion – Israel Institution of Technology, Haifa, Israel. Dr. Lavon is the chair of several advisory committees for the Israel Ministry of Health, including the Advisory Committee for Preparedness and Response to Toxicological Mass Casualties Events and the National Committee for Antidotes. Dr. Lavon served for several years as a medical consultant at the Israel Poison Information Center, and he is the former director of the Patient Safety and Risk Management Unit at Carmel Medical Center.
Jacob Lebin, MD
Assistant Professor, Emergency Medicine
University of Colorado
Dr. Jacob Lebin is a board-certified emergency physician and medical toxicologist at the University of Colorado. He completed his medical degree at the University of Colorado School of Medicine, followed by an emergency medicine residency at the University of Washington and a fellowship in medical toxicology at the University of California, San Francisco.
His clinical time is split between the University of Colorado Hospital’s emergency department and the medical toxicology consultation service associated with the Rocky Mountain Poison Center. His research interests include best practices for the management of alcohol withdrawal and the use of clinical decision support for the treatment of alcohol and opioid use disorder."
Sarah Eliza Lockwood, MD, FACMT
Medical Affairs Lead, Senior Science Fellow
Bayer U.S. Crop Science
S. Eliza Lockwood, MD, FACMT is an emergency medicine physician and medical toxicologist with a strong commitment to global health. After completing her Medical Toxicology fellowship at NYU in 2006, she returned to Washington University in St. Louis, where she established an ACGME-accredited fellowship in Medical Toxicology. Over the next decade, Dr. Lockwood became deeply engaged in global health and humanitarian efforts. She organized a relief mission to Haiti following the 2010 earthquake, founded the Global Health Scholar Track within the Washington University Division of Emergency Medicine, and served as one of the Global Health Scholars. Recognizing the need for sustainable solutions in global health, particularly around malnutrition and insect-borne diseases—two prevalent public health issues in developing countries—Dr. Lockwood began working as the Medical Affairs Lead for Bayer. In this role, she focuses on leveraging innovative agricultural and chemical technologies to address these critical challenges. Dr. Lockwood has lectured extensively, both nationally and internationally, on a wide array of topics in medical toxicology and global health.
Jennifer Love, MD
Assistant Professor of Emergency Medicine
The Mount Sinai Hospital
Dr. Jennifer Love is an Assistant Professor of Emergency Medicine at The Mount Sinai Hospital and a physician-scientist whose work centers on the emergency care of patients with substance use disorders. As part of the Mount Sinai Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND Center), she investigates novel adulterants in the opioid supply, including xylazine, and their clinical implications in emergency settings. Dr. Love is also deeply committed to advancing gender equity in medicine through education, advocacy, and research. She currently serves as Vice President of Education for the Academy for Women in Academic Emergency Medicine (AWAEM), leading national educational initiatives and workshops. Her published research has examined gender disparities in medical toxicology authorship, and her ongoing work explores representation in leadership across the field. Dr. Love earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania, where she also completed her residency and chief residency in emergency medicine, followed by a medical toxicology fellowship at Oregon Health & Science University and a T32 research fellowship at Mount Sinai. Outside of work, she enjoys cooking, ballet, and spending time with her family.
Sebastian Medina, PhD
Assistant Professor, Department of Pharmaceutical Sciences
University of New Mexico
My research centers on the toxicology of environmental metals and their impacts on human health. I am particularly interested in elucidating the mechanisms of metal-induced toxicity in hematopoietic stem and progenitor cells, with a specific emphasis on the hematotoxicity of inorganic and organic arsenicals. Additionally, my work investigates the mechanisms of immune dysregulation resulting from exposure to metals and other toxicants.
Abby Montague, MD
Medical Toxicology Pediatrician
Children's Minnesota
Dr. Montague (she/her) is a triple board-certified physician specializing in pediatrics, medical toxicology, and addiction medicine. She attended medical school and residency at the University of Minnesota, followed by a fellowship in toxicology at Health Partners Institute in St. Paul. She has practiced as a hospitalist, caring for children and newborns, and as a medical toxicologist before pursuing additional training as an addiction medicine physician. Currently, she provides specialized care for hospitalized children of all ages affected by accidental poisonings, intentional overdoses, environmental toxic exposures, envenomation, or substance use disorders. Meeting adolescents in crisis from depression or substance use disorders and helping them find hope on their path to healing is a specific passion of hers. As is providing compassionate, non-judgmental care for infant/parent dyads affected by substance use and advocating for equitable care for populations affected by those issues. She has presented at the local, regional, national, and international levels to expand education on these topics. She is the chair of the American Academy of Clinical Toxicology pediatric section, and the Toxicology consult service line leader. When not pursuing excellence in medicine, she enjoys crafting, golfing, and cooking with mediocrity and adventures with her husband and sons.
Maria Moreira MD, FACEP
Chief Education Officer, Designated Institutional Official for Graduate Medical Education Programs Denver Health & Hospital Authority, Professor of Emergency Medicine University of Colorado School of Medicine
Denver Health
Maria Moreira, MD, FACEP is the Chief Education Officer at Denver Health and Hospital Authority, the Designated Institutional Official for Graduate Medical Education programs at Denver Health, and a Professor of Emergency Medicine at the University of Colorado School of Medicine. Dr. Moreira received her medical degree from University of Medicine and Dentistry of NJ - Robert Wood Johnson Medical School and completed her Emergency Medicine Residency at Denver Health and Hospital Authority, serving as Chief Resident in her last year of training. Previous positions have included Medical Director of Continuing Education and Simulation in the Office of Education at Denver Health (2018-2026), Director of Professional Development and Wellbeing for the Emergency Department at Denver Health (2020-2026), and Program Director of the Denver Health Residency in Emergency Medicine (2010-2018). She is an active member of several national Emergency Medicine organizations including ACEP, SAEM, and CORD serving on multiple different committees. She served as President of CORD from 2019-2020. Additionally, she is the Section Editor for Adult Trauma for UpToDate, co-editor for Communication in Emergency Medicine and Emergency Medicine Secrets, Editor-in-Chief of PEERcert+, and an Associate Editor for Rosen's Emergency Medicine: Concepts and Clinical Practice 11th Edition. She has received local, regional, and national teaching awards including the John Marx Education Award from the CO ACEP Chapter, the ACEP National Emergency Medicine Faculty Teaching Award, the Michael P. Wainscott Program Director Award, the Denver Health Medical Staff Outstanding Teacher Award, the Denver Health Residency in Emergency Medicine Jeffrey Druck Legacy Teaching Award, the 2024 Denver Health Residency in Emergency Medicine Outstanding Medical Student Educator Award, and was nominated in 2018 for the ACGME Parker J. Palmer Courage to Teach Award. She has authored multiple book chapters and peer reviewed publications, lectures locally, regionally, nationally, and internationally on various clinical and educational topics, and has developed and implemented several curriculums. Areas of academic interest include curriculum development, procedure education, trauma care, communication, simulation, and leadership development.
Brent Morgan, MD
Fellowship Director
Georgia Poison Center
Dr. Morgan is a Professor and Vice Chair in the Department of Emergency Medicine at Emory University. Dr. Morgan obtained his M.D. degree from The Ohio State University College of Medicine in 1991. He completed an Emergency Medicine residency in 1994 at MetroHealth Medical Center in Cleveland and a Medical Toxicology fellowship at Carolinas Medical Center in 1996. He is board certified in Emergency Medicine and Medical Toxicology. In 2000, Dr. Morgan founded a combined Medical Toxicology fellowship training program with the Centers for Disease Control and Prevention (CDC), Emory University and the Georgia Poison Center. He serves as the Director of the Medical Toxicology fellowship and is the Chief of the Medical Toxicology section. Dr. Morgan established and directs the Georgia Occupational and Environmental Toxicology clinic at Grady Memorial Hospital. It is the only clinic in the state Georgia certified by the Association of Occupational and Environmental Clinics. Dr. Morgan is the Director of the Southeastern United States for Advanced Hazmat Life Support. Through this educational program Dr. Morgan has instructed > 1000 health care providers in the proper care of the hazmat patient.
Dr. Morgan is a nationally and internationally known expert in Medical Toxicology. He has delivered lectures and seminars in numerous countries including, India, France, Lebanon, Oman, Greece, Spain, Thailand, and the United Arab Emirates. He has trained physicians from Oman, The Kingdom of Saudi Arabia, Thailand, Lebanon and Pakistan in the practice of medical toxicology.
Nicholas Nacca, MD, FACMT
Associate Professor of Emergency Medicine
University of Rochester Medical Center
Dr. Nicholas Nacca is the director of Medical Toxicology and Medical Toxicology Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.

HoanVu Nguyen, MD
Medical Toxicologist
David Grant Medical Center, Office of Military Medicine
Military Assistant Program Director for a civilian partnered emergency medicine residency training program. Contributor, consultant, and instructor for chemical, biological, nuclear, and radiologic threat defense.
Ayrn O'Connor, MD, FACMT
Senior Medical Director & Professor
Renibus Therapeutics Inc & Arizona College of Medicine Phoenix
Ayrn O'Connor, MD, FACMT, holds dual board certification in Emergency Medicine and Medical Toxicology. She completed her medical degree and training at Indiana University School of Medicine. Dr. O’Connor is Professor, Department of Emergency Medicine and Medicine at the University of Arizona College of Medicine – Phoenix. A recognized expert in her field, she contributes to advancing medical toxicology through her leadership roles, clinical scholarship, and dedication to education and research. As Senior Medical Director at Renibus Therapeutics she is leveraging her unique skill set to inform the development of safe, innovative therapeutics.
Simon Ostrowski, MD
Assistant Professor of Emergency Medicine and faculty in the division of medical toxicology
University of Massachusetts Chan Medical School
Simon Ostrowski graduated from Boston University for his undergraduate degree and University of Massachusetts Medical School. He went on to complete his emergency medicine residency and medical toxicology fellowship at University of Pittsburgh Medical Center. Following fellowship, Dr. Ostrowski accepted a faculty position in emergency medicine and medical toxicology at UMass Chan Medical School. His academic interests include alcohol withdrawal, addiction medicine, and the intersection of toxicology and public health particularly the emergence of novel psychoactive substances.
Anthony Pizon, MD, FACMT
Chief of Medical Toxicology Division, Professor of Emergency Medicine
University of Pittsburgh
Dr. Anthony (Tony) Pizon received his medical degree from the University of Toledo School of Medicine in 2001. He then completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and his Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is currently a Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Chief of the Division of Medical Toxicology and Director of the Medical Toxicology Fellowship at UPMC. He is also Assistant Medical Director of both the Pittsburgh and West Virginia Poison Centers. Yet, most importantly, he is blessed with amazing wife, Caryn, and four wonderful children (Benjamin, Elizabeth, Gabriela, and Seraphina).
Robert "Cole" Pueringer, MD
Medical Toxicologist, Addiction Medicine Specialist, Hospitalist
Essentia Health in Duluth
Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.
Dan Repplinger, MD, FACMT
Senior Medical Safety Director
Genentech
Dan Repplinger is currently working as a Senior Medical Safety Director at Genentech. He also is a volunteer clinical faculty at Zuckerberg San Francisco General Hospital and Trauma Center. He received his medical degree from the University of Wisconsin-Madison. He is a board-certified specialist in emergency medicine, addiction medicine, and medical toxicology.
Elaine Rigney, MD,
Medical Toxicology Fellow
University of Rochester
Dr. Elaine P. Rigney is an medical toxicology fellow at the University of Rochester Medical Center. She completed her medical degree at SUNY Downstate College of Medicine, followed by an internal medicine residency at the University of Rochester. She presently serves as an ACMT FIT board member. Prior to fellowship she worked in the Division of Medicine in Psychiatry as a hospitalist and primary care provider treating patients with complex psychiatric and medical comorbidities.
Daniel J. Sessions, MD, FACMT, FASAM, FAAEM
Chief of Medical Toxicology, Interim Chair of Emergency Medicine
Ochsner Medical Center
Dr. Sessions practices serves as Interim Chair of Emergency Medicine and Chief of Medical Toxicology at Ochsner Medical Center - New Orleans. He also leads a Medication Assisted Treatment for Opioid Use Disorder expansion program for Ochsner Health Foundation. He completed a Medical Toxicology fellowship at the Rocky Mountain Poison & Drug Center at Denver Health in 2013. He is board-certified in Addiction Medicine by the American Board of Preventive Medicine. He is President-elect of the American College of Emergency Physicians Toxicology Section. He holds academic appointments at Xavier Ochsner College of Medicine and University of Queensland, Ochsner Clinical School.
Meghan Spyres, MD, FACMT
Clinical Associate Professor of Emergency Medicine
Banner – University Medical Center Phoenix
Dr. Spyres received her MD from Columbia University College of Physicians and Surgeons in New York City and stayed in New York to complete an Emergency Medicine residency at Bellevue/New York University. She completed her Medical Toxicology fellowship training in 2016 at Banner—University Medical Center in Phoenix, Arizona. She is currently Associate Professor of Clinical Emergency Medicine at the University of Arizona College of Medicine Phoenix and faculty in the department of Medical Toxicology at Banner—University Medical Center Phoenix. Her research interests include envenomations, emerging drugs of abuse, gender in medicine, and the intersection of critical care and toxicology. She is co-founder of Women in Toxicology, a subgroup of ACMT that promotes women in academic medicine. Additionally, she is part the leadership team for ACMT’s Toxicology Investigators Consortium Registry (ToxIC), focusing on detecting trends in novel drugs of abuse.
Taylor Wahrenbrock, MD MPH
Clinical Toxicology Fellow, Emergency Medicine Physician
Virginia Commonwealth University
Taylor Wahrenbrock is an emergency medicine physician and second-year clinical toxicology fellow at Virginia Commonwealth University. She received her medical degree from The George Washington University School of Medicine and completed residency at Cook County Hospital.
Christopher James Watson, MD
Medical Toxicologist
Maine Medical Center
James Watson is a board certified medical toxicologist and emergency medicine physician practicing at Maine Medical Center and the Northern New England Poison Center, and is an Assistant Professor in the Department of Emergency Medicine at Tufts University School of Medicine. James graduated from the University of Chicago Pritzker School of Medicine in 2017 before completing residency training at the Harvard Affiliated Emergency Medicine Residency at Beth Israel Deaconess Medical Center and fellowship training at the Harvard Medical Toxicology Program at Boston Children’s Hospital; both in Boston, Massachusetts. His academic interests include medical education, resource utilization within medical toxicology, and critical care toxicology. James is a Portland native, and lives in Southern Maine with his wife, son, and rescue dog Mowgli.
Bern Weigel, MD
Medical Toxicologist
Northwestern University Feinberg School of Medicine
Dr. Ben Weigel is an emergency medicine physician in Chicago, Illinois and is affiliated with multiple hospitals in the area, including Northwestern Medicine-Northwestern Memorial Hospital and University of Illinois Hospital. He received his medical degree from Tufts University School of Medicine
Stephanie Weiss, MD, PhD
Staff Clinician, Translational Addiction Medicine Branch
NIDA/NIH
Dr. Stephanie Weiss is the Staff Research Physician serving the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in addiction medicine and medical toxicology and participated in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the NIDA IRP mission of conducting inpatient and outpatient proof-of-concept human laboratory therapeutic and imaging studies for addictive disorders. Her research interests include GLP-1RAs, medication misuse, and improving interpretation of urine drug testing.
Timothy J. Wiegand, MD, FACMT, DFASAM
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
Brandtly Yakey, DO
Emergency Physician
Michigan Poison and Drug Information Center; Henry Ford Health System Department of Emergency Medicine, Detroit, MI
Dr. Brandtly Yakey completed his Emergency Medicine residency at Sparrow/(formerly Michigan State University) and a Medical Toxicology Fellowship at the Wayne State University/Detroit Medical Center. He currently works as an emergency physician at Henry Ford Hospital and takes call for the Michigan Poison & Drug Information Center. He is the current Education Director of the MiPDC. He was the 2025 recipient of the Charles E. Becker Medal for Outstanding Achievement as a Medical Toxicology Fellow.
Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. It is expected that learners will receive up to 16.00 for learning and change.
Available Continuing Educations Credits:
- Continuing Medical Education (CME)
- Continuing Pharmacist Education (CPE)
Activity Overview
This activity aligns with the healthcare team's professional scope by providing access to current Medical Toxicology research and fostering engagement in advocacy issues relevant to their practice.
Target Audience
This activity is designed for an audience of: physicians, pharmacists,
Criteria for Success
Certificates of completion will be awarded based on the participant's attendance. A certificate of completion will be available upon completion of an online evaluation/claim credit form available at:
Please claim your credit by April 22, 2026
If you have questions about this CE activity, please contact AKH Inc at [email protected]
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 17.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare, designates this continuing education activity for 17.0 contact hours.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Continuing Education

2026 ACMT Total Tox Course - Neuropsychiatric & Cardiovascular Pharmaceutical Toxicity Live Webinar Friday December 4, 2026
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
Criteria for Success There is no fee to participate in this activity. Certificate of completion will be awarded based on the participant's attendance. A certificate of completion will be available upon completion of an online evaluation/claim credit form available at: https://education.acmt.net/p/2024TTC-SU-EP
Please claim your credit by December 8, 2027
If you have questions about this CE activity, please contact AKH Inc at [email protected]
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 16.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 16.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 16.0 AAPA Category 1 CME credits.
PAs should only claim credit commensurate with the extent of their participation.
Pharmacists AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 16.0 contact hour
Commercial Support This activity is supported from an independent medical education grant from BTG international lnc.,
Disclosures It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Hotel – Discounted Group Block
ACMT has secured a discounted rate for attendees of our 2027 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the conference hotel for the best selection and price!
Sheraton New Orleans Hotel
500 Canal St
New Orleans, LA 70130
Exclusive hotel rate available until March 8, 2027 or when room block is filled, whichever comes first.
If you would prefer to call-in to make your reservation, the Sheraton New Orleans Hotel phone line is (504)-525-2500.